Transcend Capital Advisors’s Tenet Healthcare THC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$260K Sell
1,389
-278
-17% -$51.1K 0.02% 683
2026
Q1
$315K Sell
1,667
-124
-7% -$26.1K 0.03% 528
2025
Q4
$356K Buy
1,791
+169
+10% +$34.2K 0.03% 471
2025
Q3
$329K Buy
+1,622
New +$288K 0.02% 502

Other funds holding THC

Transcend Capital Advisors's THC Position: Q2 2026 in Review

Transcend Capital Advisors reduced its Tenet Healthcare (THC) stake by 17% in Q2 2026, selling an estimated $51.1K and leaving 1,389 shares worth $260K. The position accounts for 0.02% of the portfolio, ranked #683.

Transcend Capital Advisors first reported a position in THC in Q3 2025 and has held it in 4 quarters since. The position peaked at $356K in Q4 2025. 681 funds tracked by Wall St. Rank hold THC as of Q2 2026.

  • Transcend Capital Advisors held 1,389 shares of Tenet Healthcare worth $260K as of Q2 2026.
  • Transcend Capital Advisors sold 278 Tenet Healthcare shares in Q2 2026, an estimated $51.1K.
  • Tenet Healthcare made up 0.02% of Transcend Capital Advisors's portfolio in Q2 2026, its #683 holding.
  • Transcend Capital Advisors first reported a position in Tenet Healthcare in Q3 2025 and has held it in 4 quarters since.
  • Transcend Capital Advisors's Tenet Healthcare position peaked at $356K in Q4 2025.
  • 681 funds tracked by Wall St. Rank held Tenet Healthcare as of Q2 2026.

Based on Transcend Capital Advisors's 13F filing for Q2 2026, filed 4 Aug 2026.